Symbol: |
KIAA1614
|
Description: |
KIAA1614 [Source:HGNC Symbol;Acc:29327]
|
Location: |
Chr1:180882290-180920750[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:126
Gene |
Compound |
Gen_sig |
Exp_pattern |
KIAA1614 |
NSC 717092 |
0.023 |
Up |
KIAA1614 |
NSC 717471 |
0.018 |
Down |
KIAA1614 |
NSC 718131 |
0.025 |
Down |
KIAA1614 |
NSC 718579 |
0.01 |
Down |
KIAA1614 |
NSC 718652 |
0.01 |
Down |
KIAA1614 |
8-chloro-3-(4-methylphenylamino)-7-methoxycarbonyl-1,2,4-tri azolo[4,3-b][1,2,4]benzodithiazine 5,5-dioxide |
0.003 |
Up |
KIAA1614 |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.028 |
Up |
KIAA1614 |
6-(3-Aminopropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo- 3-nitro-11H-indeno[1,2-c]isoquinoline Hydrochloride Salt |
0.004 |
Up |
KIAA1614 |
Everolimus |
0.02 |
Up |
KIAA1614 |
gamma-glutamyl-alpha-amino-beta-[[2-ethyl(5-fluoro-2'deoxyur idyl) N-methyl-N-(4-chlorobutyl)phosphoramidoyl]sulfonyl] propionyl-(R)-(-)-phenylglycine |
0.024 |
Up |
KIAA1614 |
NSC 735333 |
0.011 |
Up |
KIAA1614 |
NSC 736189 |
0.011 |
Up |
KIAA1614 |
7-(2-Pyrrolidinoethyl)oximino-5-androsten-3b,17b-diol diacetate |
0.023 |
Down |
KIAA1614 |
(-)-dactylolide |
0.048 |
Down |
KIAA1614 |
6-(3-Aminopropyl)-9-ethoxy-5,6-dihydro-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.005 |
Up |
Expression pattern: Sensitivity / Resistance
Total:9 Current:8
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:8
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:34
Total:3 Current:1
[First] [Prev]  Next Last 
|